Detalhe da pesquisa
1.
IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy.
Haemophilia
; 29(1): 135-144, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423202